論文 - 詳細
| RRC ID | 43897 |
|---|---|
| 著者 | Ohgidani M, Ichihara H, Goto K, Matsumoto Y, Ueoka R. |
| タイトル | Anticancer effects of residual powder from Barley-Shochu distillation remnants against the orthotopic xenograft mouse models of hepatocellular carcinoma in vivo. |
| ジャーナル | Biol Pharm Bull |
| Abstract |
Barely-Shochu is a traditional Japanese liquor distilled from fermented barley with Saccharomyces cerevisiae. Barely-Shochu distillation remnants (SDR) are by-products in the manufacturing process of barley-Shochu. We have already reported on valuable powder from Shochu distillation remnants (PSDR) including antioxidative compounds such as polyphenols. In this study, we investigated the therapeutic effects of barely-PSDR against orthotopic xenograft mouse models of hepatocellular carcinoma (HCC) in vivo. We constructed a mouse model of HCC by orthotopical inoculation of HepG2 cells into the liver of SCID mice. Barely-PSDR (2250 mg/kg) was orally treated once each day for 21 d after the inoculation of HepG2 cells. The livers were removed from anaesthetized mice after the treatment with barely-PSDR and fixed in formalin. The liver sections were analyzed by hematoxylin and eosin (HE) staining and terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate (dUTP) nick-end labeling (TUNEL) methods. Remarkably high reduction of tumorigenesis was obtained in the mouse models of HCC after the oral administration of barely-PSDR in vivo. Induction of apoptosis in the liver section on the mouse models treated with barely-PSDR was observed. Furthermore, prolonged survival was obtained. Thus, therapeutic effects of barely-PSDR without side effects on the orthotopic xenograft mouse models were revealed for the first time. |
| 巻・号 | 35(6) |
| ページ | 984-7 |
| 公開日 | 2012-1-1 |
| DOI | 10.1248/bpb.35.984 |
| PII | DN/JST.JSTAGE/bpb/35.984 |
| PMID | 22687544 |
| MeSH | Animals Antineoplastic Agents, Phytogenic / pharmacology Antineoplastic Agents, Phytogenic / therapeutic use* Apoptosis / drug effects Carcinoma, Hepatocellular / drug therapy* Carcinoma, Hepatocellular / pathology Distillation Female Hep G2 Cells Hordeum* Humans Liver Neoplasms / drug therapy* Liver Neoplasms / pathology Mice Mice, SCID Plant Extracts / pharmacology Plant Extracts / therapeutic use* Tumor Burden / drug effects Xenograft Model Antitumor Assays |
| IF | 1.863 |
| 引用数 | 6 |
| WOS 分野 | PHARMACOLOGY & PHARMACY |
| オルトメトリクス指標 |
オルトメトリクス指標項目
|
| 最多言及媒体 | Patent(IFI CLAIMS) |
| 各媒体での言及数の合計 | 3 |
| 過去6か月間でのオルトメトリクス指標の変動値 | 0.0 |
| リソース情報 | |
| ヒト・動物細胞 | RERF-LC-AI(RCB0444) HuH-7 Hep G2 |